Factor V resistance to activated protein C
DOI:
https://doi.org/10.51481/amc.v41i2.510Keywords:
Trombosis, trombofilia, estado hipercoagulable, resistencia delfactor V a la proteína C activada.Abstract
A case of a 15 year old boy with deep venous thrombosis after a mild trauma is described. Studies demostrated resistance to activated protein C. Family studies disclosed the same deficiency in several members ofhis family. Key words: Thrombosis, thrombophilia, hypercoagulable states, activated protein C resistance.
Downloads
References
Bertina RM, Koeleman BPC, KosterT, Rosendaal R, Dirven RS, De Ronde H, Van der Velden PA, Reitsma PH. Mutation in Blood Coagulation Factor V Associated with Resistance to Activated Protein C Nature. 1994, 69:64-67.
Dahlbáck B. Inherited Thrombophilia: Resistance to Activated Protein C as a Pathogenic Factor for Venous Thromboembolism. Blood, 1995, 85:607-614.
Koeleman BPC. Reitsma P, HB Allaart CF and Bertina RM. Activated Protein C Resistance as an Addiotional Risk Factor for Thrombosis in Protein C Deficient Families. Blood. 1994, 84:1031-1035.
De Ronde H and Bertina RM. Laboratory Diagnosis of APCResistance: A Critical Evaluation of Test and The Developmen of Diagnostic Criteria. Thromb Haemost. 1994, 72:880-886.
Dahlbáck B, Carlsson M and Svensson P J. Familial Thrombophilia Due to a Previously Unrecognized Mechanism Charaterized by Poor Anticoagulant Response to Acti vated Protein C; prediction of a Cofactor to Activated Protein C. Proc Natl Acad Sciences USA, 1993, 90:1004-1008.
Sinfontes MT, Nuss R, Jacobson LL. Griffin JH, Manco-Johnson M. Thrombosis in Otherwise Well Children with the Factor V Leiden Mutation. J Pediatr, 1996, 128:324-328.
Grandille JS, Greengard M, Alhenc Gelas M, Juhan-Vague J, Abgrall JF, Jude 8, Grifin JH, Aicach M and the French Network on the Behalf of INSERM. Incidence of Activated Protein C Resistance caused by the Arg 506 Gln Mutation in Factor V in 113 Unrelated Symptomatic Protein C Deficient Patients. Blood, 1995, 86:219-224.
Heeb MJ, Kojima V, Greemgard JS and Griffin JH. Activated
Protein C Resistance: Molecular Mechanims Based on studies Using Purified Gin-Factor V. Blood, 1995, 85:3405-3411.
Rosendaal FR, KosterT, Vandenbroucke JP and Reitsma PH High Risk of Thrombosis in Patients Homozygous for Factor V Leiden (Activated Protein C Resistance). Blood, 1995, 85:1504-1508.
Koster T, Rosendaal FR, De Ronde H, VBriet E, Vanderbroucke JP and Bertina RM. Venous Thrombosis due to Poor Anticoagulant Reponse to APC: Leiden Thrombophilia Study Lancet. 1993, 342:1053-1056.
l l . Svensson PJ, and Dahlbáck B. Resistance to Activated Protein C as Basis for venous Thrombosis. N Engl J Med. 1994, 330:517520.
Herrmann FH, Koesling M, Schroder M, Altman, R Jiménez Bonilla, R Lopaciuk S, Pérez Requejo Jl, Singh JR. Prevalence of Factor V Leiden Mutation in Various Populations. Genet Epidemiol. 1997,
Zoller B , Bersdatter A, Garcia de Frutos P, Dahlbáck B. Resistance to Activated Protein C as an Additional Genetic Risk Factor in Hereditary Deficiency of Protein S. Blood. 1995, 85:3518-3523.
Oliviero O, Frisso S, Manzato F, Guella A, Bernardi F, Lunghi B, Girelli D, Azzini M, Brocco G, Russo C and Corrocher R. Resistance to Activated Protein C in Healthy women Taking Oral Contraceptives. Br J Haematol. 1995, 95:465-470.
Bucalossi A, Marotta G, Bigazzi C, Galieni P and Dispensa E. Reduction of Antithrombin Ill Protein C and Protein S Levels and Activated Protein C Resistance in Polycythemia Vera and Essential Thrombocythemia atients with Thrombosis. Am J Hematol. 1996, 52:14-20.
Downloads
Published
Issue
Section
License
Copyright (c) 2009 Acta Médica Costarricense
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)
